(Q36236624)
Statements
Growth factor signalling and resistance to selective oestrogen receptor modulators and pure anti-oestrogens: the use of anti-growth factor therapies to treat or delay endocrine resistance in breast cancer (English)
Nicholson RI
Hutcheson IR
Knowlden JM
Giles M